5,6,7,8-Tetrahydro[1,2,4]triazolo[4,3-a]pyrazine hydrochloride, 97.0%, 1g

3-Boc-Amino-2,6-dioxopiperidine, 95.0%, 10g

2-Bromoquinoline, 97.0%, 500g

4-Chloro-2-(trifluoromethyl)benzoic acid, 95.0%, 100g

5-Amino-1-(2-bromo-5-fluoro-phenyl)-1H-pyrazole-4-carbonitrile, 95.0%, 1g

Methyl 3-methoxypropanoate, 99.0%, 25ml

1-Fluoro-9H-carbazole, 95%, 5g

3-Chloro-2,4,5-trifluoro-6-nitrobenzoic acid, 97%, 250mg

METHYL 5-BROMO-7-AZAINDOLE-6-CARBOXYLATE, 97.0%, 100mg

[S(R)]-N-[(1S)-1-[3',5'-Bis(1,1-dimethylethyl)[1,1'-biphenyl]-2-yl]-2-(diphenylphosphino)ethyl]-2-methyl-2-propanesulfinamide, 95%, 25mg

8-Hydroxyquinoline-2-carboxaldehyde, 95.0%, 25g

GC capillary column ROTI®Cap-5, 50 m, 0.25 mm, 1.00 µm, 1 Piece(s)

Di-tert-butyl bicyclo[1.1.1]Pentane-1,3-diyldicarbamate, 98%, 1g